Cardinal Health Change in Accounts Receivable 2010-2024 | CAH

Cardinal Health annual/quarterly change in accounts receivable history and growth rate from 2010 to 2024. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
  • Cardinal Health change in accounts receivable for the quarter ending December 31, 2024 was $-0.253B, a 47.29% decline year-over-year.
  • Cardinal Health change in accounts receivable for the twelve months ending December 31, 2024 was $-1.223B, a 35.02% decline year-over-year.
  • Cardinal Health annual change in accounts receivable for 2024 was $-0.996B, a 4.84% increase from 2023.
  • Cardinal Health annual change in accounts receivable for 2023 was $-0.95B, a 32.38% decline from 2022.
  • Cardinal Health annual change in accounts receivable for 2022 was $-1.405B, a 55.42% increase from 2021.
Cardinal Health Annual Change in Accounts Receivable
(Millions of US $)
2024 $-996
2023 $-950
2022 $-1,405
2021 $-904
2020 $82
2019 $-751
2018 $-871
2017 $-665
2016 $-866
2015 $-870
2014 $925
2013 $216
2012 $-129
2011 $-457
2010 $21
2009 $-714
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $35.386B $226.827B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $86.050B 20.78
Becton Dickinson (BDX) United States $50.254B 12.44
Straumann Holding AG (SAUHY) Switzerland $21.670B 0.00
Labcorp (LH) United States $20.926B 16.97
Cooper (COO) United States $16.350B 21.69
West Pharmaceutical Services (WST) United States $15.509B 32.51
Align Technology (ALGN) United States $13.803B 27.40
Henry Schein (HSIC) United States $8.586B 14.73
Merit Medical Systems (MMSI) United States $5.769B 27.89
DENTSPLY SIRONA (XRAY) United States $3.308B 9.88
CONMED (CNMD) United States $1.858B 13.90
STAAR Surgical (STAA) United States $0.941B 0.00
Lifevantage (LFVN) United States $0.153B 15.75
Pro-Dex (PDEX) United States $0.139B 15.18